CA Stock MarketDetailed Quotes
AREV AREV Life Sciences Global Corp
- 0.090
- 0.0000.00%
15min DelayTrading Apr 11 09:30 ET
2.86MMarket Cap-9000P/E (TTM)
0.000High0.000Low0Volume0.000Open0.090Pre Close0.00Turnover0.12052wk High0.00%Turnover Ratio31.76MShares0.09052wk Low-0.01EPS TTM1.51MFloat Cap1306.800Historical HighLossP/E (Static)16.83MShs Float0.050Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM-3.33P/B1Lot Size--Div YieldTTM
AREV Life Sciences Global Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | -80.74%49.11K | -94.92%7.21K | -12.82%23.09K | -76.41%10.19K | -79.74%8.63K | 33.80%255K | 163.64%141.99K |
| Operating revenue | --0 | --0 | --0 | -80.74%49.11K | -94.92%7.21K | -12.82%23.09K | -76.41%10.19K | -79.74%8.63K | 33.80%255K | 163.64%141.99K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -88.48%27.98K | -84.69%119.53K | -67.84%166.03K | -24.86%1.44M | -126.35%-95.9K | 5.62%242.9K | 8.11%780.52K | -13.17%516.34K | 127.76%1.92M | 80.83%363.94K |
| Selling and administrative expenses | -100.93%-1.86K | -89.06%74K | -68.36%145.62K | -21.64%1.19M | -144.61%-144.75K | 14.55%199.79K | 12.91%676.61K | -4.51%460.28K | 253.61%1.52M | 58.28%324.44K |
| -Selling and marketing expense | --0 | --0 | --0 | 10.57%205.91K | 48.82%-35.83K | 605.05%37.95K | 78.14%71.94K | -7.47%131.85K | 3,418.12%186.21K | -3,452.73%-70.01K |
| -General and administrative expense | -101.15%-1.86K | -87.76%74K | -55.66%145.62K | -26.14%986.01K | -127.61%-108.92K | -4.25%161.84K | 8.19%604.66K | -3.26%328.43K | 214.19%1.33M | 94.41%394.45K |
| Research and development costs | --0 | -50.59%27.22K | --0 | -43.36%84.02K | 140.81%6.56K | -53.08%5.24K | 198.84%55.09K | -74.36%17.13K | 15.87%148.33K | 75.77%-16.07K |
| Depreciation amortization depletion | -57.40%13.84K | -58.56%13.84K | -55.20%13.84K | -14.24%125.59K | -18.93%28.83K | -12.37%32.48K | -11.34%33.4K | -14.58%30.89K | -1.48%146.45K | -5.74%35.56K |
| -Depreciation and amortization | -57.40%13.84K | -58.56%13.84K | -55.20%13.84K | -14.24%125.59K | -18.93%28.83K | -12.37%32.48K | -11.34%33.4K | -14.58%30.89K | -1.48%146.45K | -5.74%35.56K |
| Other operating expenses | 197.07%16K | -70.96%4.48K | -18.39%6.57K | -59.97%42.32K | -32.72%13.46K | -26.55%5.39K | -76.84%15.43K | -17.13%8.05K | -22.77%105.72K | -19.64%20.01K |
| Operating profit | 87.27%-27.98K | 84.48%-119.53K | 67.30%-166.03K | 16.31%-1.39M | 146.46%103.11K | -8.02%-219.81K | -13.48%-770.33K | 8.04%-507.72K | -155.17%-1.67M | -50.57%-221.95K |
| Net non-operating interest income (expenses) | 73.33%-945 | 42.47%-944 | 50.63%-939 | 86.83%-6.09K | 87.57%-1.16K | 68.00%-3.54K | 85.72%-1.64K | 86.76%-1.9K | 21.40%-46.23K | 47.31%-9.3K |
| Non-operating interest expense | -73.33%945 | -42.47%944 | -50.63%939 | -86.83%6.09K | -87.57%1.16K | -68.00%3.54K | -85.72%1.64K | -86.76%1.9K | -21.40%46.23K | -47.31%9.3K |
| Other net income (expenses) | 64.14%-350 | -405.26%-2.4K | -105.99%-43.28K | -103.05%-22.38K | 72.87%-1.45K | 80.35%-976 | -475 | 314.46%722.55K | 732.87K | |
| Gain on sale of security | ---- | 64.14%-350 | -405.26%-2.4K | -745.41%-3.69K | -3,186.76%-2.24K | ---1.45K | -165.22%-976 | ---475 | 99.23%-436 | ---68 |
| Special income (charges) | --0 | ---- | ---- | -105.59%-39.59K | -102.80%-20.14K | --0 | ---- | ---- | 353.08%708.64K | 356.64%718.58K |
| -Less:Other special charges | ---- | ---- | ---- | 102.06%14.7K | 99.34%-4.76K | ---- | ---- | ---- | ---713.26K | ---718.58K |
| -Less:Write off | ---- | ---- | ---- | 437.87%24.9K | ---- | ---- | ---- | ---- | -94.21%4.63K | --0 |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --14.36K | ---- |
| Income before tax | 87.13%-28.93K | 84.37%-120.83K | 66.80%-169.37K | -45.82%-1.44M | -84.13%79.58K | -2.22%-224.8K | -11.17%-772.94K | 9.95%-510.09K | 5.58%-990.31K | 199.93%501.62K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 87.13%-28.93K | 84.37%-120.83K | 66.80%-169.37K | -45.82%-1.44M | -84.13%79.58K | -2.22%-224.8K | -11.17%-772.94K | 9.95%-510.09K | 5.58%-990.31K | 199.93%501.62K |
| Net income continuous operations | 87.13%-28.93K | 84.37%-120.83K | 66.80%-169.37K | -45.82%-1.44M | -84.13%79.58K | -2.22%-224.8K | -11.17%-772.94K | 9.95%-510.09K | 5.58%-990.31K | 199.93%501.62K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 87.98%-28.93K | 84.37%-120.83K | 66.80%-169.37K | -45.82%-1.44M | -84.13%79.58K | -9.43%-240.65K | -11.17%-772.94K | 9.95%-510.09K | 5.58%-990.31K | 199.93%501.62K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 87.98%-28.93K | 84.37%-120.83K | 66.80%-169.37K | -45.82%-1.44M | -84.13%79.58K | -9.43%-240.65K | -11.17%-772.94K | 9.95%-510.09K | 5.58%-990.31K | 199.93%501.62K |
| Diluted earnings per share | 90.89%-0.0009 | 87.32%-0.0038 | 50.00%-0.01 | 0.00%-0.05 | 0 | 0.00%-0.01 | 0.00%-0.03 | 33.33%-0.02 | 28.57%-0.05 | 133.33%0.01 |
| Basic earnings per share | 90.89%-0.0009 | 87.32%-0.0038 | 50.00%-0.01 | 0.00%-0.05 | 0 | 0.00%-0.01 | 0.00%-0.03 | 33.33%-0.02 | 28.57%-0.05 | 133.33%0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg